References and Notes
<A NAME="RU02508ST-1">1</A>
Curran DP.
Qi H.
Geib SJ.
DeMello NC.
J. Am. Chem. Soc.
1994,
116:
3131
<A NAME="RU02508ST-2A">2a</A>
Kitagawa O.
Izawa H.
Sato K.
Dobashi A.
Taguchi T.
Shiro M.
J. Org. Chem.
1998,
63:
2634
<A NAME="RU02508ST-2B">2b</A>
Hughes AD.
Price DA.
Simpkins NS.
J. Chem. Soc., Perkin Trans. 1
1999,
1295
<A NAME="RU02508ST-2C">2c</A>
Kondo K.
Fujita H.
Suzuki T.
Murakami Y.
Tetrahedron Lett.
1999,
40:
5577
<A NAME="RU02508ST-2D">2d</A>
Ates A.
Curran DP.
J. Am. Chem. Soc.
2001,
123:
5130
<A NAME="RU02508ST-3A">3a</A>
Kitagawa O.
Kohriyama M.
Taguchi T.
J. Org. Chem.
2002,
67:
8682
<A NAME="RU02508ST-3B">3b</A>
Terauchi J.
Curran DP.
Tetrahedron: Asymmetry
2003,
14:
587
<A NAME="RU02508ST-4A">4a</A>
Kitagawa O.
Takahashi M.
Yoshikawa M.
Taguchi T.
J. Am. Chem. Soc.
2005,
127:
3676
<A NAME="RU02508ST-4B">4b</A>
Kitagawa O.
Yoshikawa M.
Tanabe H.
Morita T.
Takahashi M.
Dobashi Y.
Taguchi T.
J. Am. Chem. Soc.
2006,
128:
12923
<A NAME="RU02508ST-5">5</A>
Bennett DJ.
Pickering PL.
Simpkins NS.
Chem. Commun.
2004,
1392
<A NAME="RU02508ST-6A">6a</A>
Hata T.
Koide H.
Taniguchi N.
Uemura M.
Org. Lett.
2000,
2:
1907
<A NAME="RU02508ST-6B">6b</A>
Koide H.
Hata T.
Yoshihara K.
Kamikawa K.
Uemura M.
Tetrahedron
2004,
60:
4527
Synthesis of axially chiral N-aryl indoles by stereoselective nucleophilic aromatic substitution reactions of planar-chiral
tricarbonyl(2,6-disubstituted-1-fluorobenzene)chromium complexes, see:
<A NAME="RU02508ST-7A">7a</A>
Kamikawa K.
Kinoshita S.
Matsuzaka H.
Uemura S.
Org. Lett.
2006,
8:
1097
<A NAME="RU02508ST-7B">7b</A>
Kamikawa K.
Kinoshita S.
Furusyo M.
Takemoto S.
Matsuzaka H.
Uemura S.
J. Org. Chem.
2007,
72:
3394
<A NAME="RU02508ST-8">8</A>
Duan W.-L.
Imazaki Y.
Shintani R.
Hayashi T.
Tetrahedron: Asymmetry
2007,
63:
8529
<A NAME="RU02508ST-9">9</A>
Brandes S.
Bella M.
Kjærsgaard A.
Jørgensen KA.
Angew. Chem. Int. Ed.
2006,
45:
1147
<A NAME="RU02508ST-10A">10a</A>
Tanaka K.
Takeishi K.
Noguchi K.
J. Am. Chem. Soc.
2006,
128:
4586
<A NAME="RU02508ST-10B">10b</A>
Tanaka K.
Takeishi K.
Synthesis
2007,
2920
<A NAME="RU02508ST-11">11</A> For Rh(I)+-xyl-BINAP-catalyzed concurrent construction of both C-C and C-N axial chiralities,
see:
Oppenheimer J.
Hsung RP.
Figueroa R.
Johnson WL.
Org. Lett.
2007,
9:
3969
For our accounts, see:
<A NAME="RU02508ST-12A">12a</A>
Tanaka K.
Synlett
2007,
1977
<A NAME="RU02508ST-12B">12b</A>
Tanaka K.
Nishida G.
Suda T.
J. Synth. Org. Chem. Jpn.
2007,
65:
862
<A NAME="RU02508ST-13">13</A> For Rh(I)+-modified-BINAP-catalyzed [2+2+2] cyclo-addition of alkynes with isocyanates, see:
Tanaka K.
Wada A.
Noguchi K.
Org. Lett.
2005,
7:
4737
<A NAME="RU02508ST-14">14</A> A neutral rhodium(I)-complex-catalyzed [2+2+2] cycloaddition of alkynes with
isocyanates, see:
Kondo T.
Nomura M.
Ura Y.
Wada K.
Mitsudo T.
Tetrahedron Lett.
2006,
47:
7107
Neutral rhodium(I)-complex-catalyzed enantioselective [2+2+2] cycloadditions of alkenyl
isocyanates with alkynes, see:
<A NAME="RU02508ST-15A">15a</A>
Yu RT.
Rovis T.
J. Am. Chem. Soc.
2006,
128:
2782
<A NAME="RU02508ST-15B">15b</A>
Yu RT.
Rovis T.
J. Am. Chem. Soc.
2006,
128:
12370
<A NAME="RU02508ST-15C">15c</A>
Lee EE.
Rovis T.
Org. Lett.
2008,
10:
1231
For recent reviews of pyridone synthesis by transition-metal-catalyzed [2+2+2] cycloadditions,
see:
<A NAME="RU02508ST-16A">16a</A>
Heller B.
Hapke M.
Chem. Soc. Rev.
2007,
36:
1085
<A NAME="RU02508ST-16B">16b</A>
Chopade PR.
Louie J.
Adv. Synth. Catal.
2006,
348:
2307
<A NAME="RU02508ST-16C">16c</A>
Nakamura I.
Yamamoto Y.
Chem. Rev.
2004,
104:
2127
<A NAME="RU02508ST-16D">16d</A>
Varela JA.
Saà C.
Chem. Rev.
2003,
103:
3787
<A NAME="RU02508ST-17">17</A>
General Procedure for the [2+2+2] Cycloaddition (Tables 2 and 3)
Under an Ar atmosphere, a CH2Cl2 solution (0.5 mL) of (R)-BINAP (0.010-0.040 mmol, 5-20 mol%) was added to a CH2Cl2 solution (0.5 mL) of [Rh(cod)2]BF4 (0.010-0.040 mmol, 5-20 mol%) at r.t., and the mixture was stirred for 5 min. The
resulting solution was stirred under H2 (1 atm) at r.t. for 1 h, concentrated to dryness, and dissolved in CH2Cl2 (0.4 mL). To this solution was added a CH2Cl2 solution (0.7 mL) of 2 (0.220 mmol) and then a CH2Cl2 solution (0.9 mL) of 1 (0.200 mmol) at r.t. After stirring at r.t. for 1-18 h, the resulting solution was
concentrated and product 3 was isolated by a silica gel chromatography.
Compound (+)-3aa: colorless solid; mp 46.3-47.1 °C; [α]D
25 +44.7 (c 1.46, CHCl3, 67% ee). IR (neat): 2959, 1737, 1666, 1617, 1573, 1265 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.49-7.33 (m, 2 H), 7.33-7.20 (m, 1 H), 7.04-6.91 (m, 1 H), 3.79 (s, 3 H),
3.78 (s, 3 H), 3.49 (s, 2 H), 3.40 (s, 2 H), 2.55 (sept, J = 6.9 Hz, 1 H), 2.06 (s, 3 H), 1.79 (s, 3 H), 1.16 (d, J = 6.9 Hz, 3 H), 1.14 (d, J = 6.9 Hz, 3 H). 13C NMR (75 MHz, CDCl3): δ = 171.65, 171.59, 163.7, 150.0, 145.6, 137.1, 136.2, 129.0, 127.9, 126.9, 126.8,
120.6, 116.3, 59.2, 53.20, 53.17, 39.4, 37.6, 27.9, 24.0, 23.1, 18.0, 13.3. HRMS-FAB:
m/z calcd for C23H28NO5 [M + H]+: 398.1967; found: 398.1996. CHIRALPAK AD, hexane-2-PrOH (90:10), 1 mL/min, t
R = 8.21 min (major isomer) and 18.0 min (minor isomer).
Compound (+)-3ab: colorless solid; mp 161.1-161.8 °C; [α]D
25 +20.1 (c 1.63, CHCl3, 30% ee). IR (neat): 2954, 1739, 1732, 1667, 1615, 1575, 1265 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.39-7.20 (m, 3 H), 7.08-6.98 (m, 1 H), 3.79 (s, 6 H), 3.48 (s, 2 H), 3.40
(s, 2 H), 2.07 (s, 3 H), 2.02 (s, 3 H), 1.79 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 171.6, 171.5, 163.3, 150.1, 138.5, 135.9, 135.2, 131.1, 128.6, 127.8, 127.2,
120.7, 116.5, 59.2, 53.19, 53.17, 39.3, 37.6, 17.7, 17.3, 13.2. HRMS-FAB: m/z calcd for C21H24NO5 [M + H]+: 370.1654; found: 370.1613; CHIRALPAK AD, hexane-2-PrOH (90:10), 1.0 mL/min, t
R = 12.5 min (major isomer) and 16.0 min (minor isomer).
Compound (+)-3ac: colorless solid; mp 111.0-111.6 °C; [α]D
25 +28.8 (c 1.33, CHCl3, 39% ee). IR (neat): 2955, 1736, 1667, 1617, 1574, 1264 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.41-7.22 (m, 3 H), 7.01 (d, J = 7.5 Hz, 1 H), 3.791 (s, 3 H), 3.785 (s, 3 H), 3.49 (s, 2 H), 3.40 (s, 2 H), 2.38
(dq, J = 7.5, 7.5 Hz, 1 H), 2.28 (dq, J = 7.5, 7.5 Hz, 1 H), 2.06 (s, 3 H), 1.79 (s, 3 H), 1.13 (t, J = 7.5 Hz, 3 H). 13C NMR (75 MHz, CDCl3): δ = 171.6, 171.5, 163.5, 150.1, 140.6, 138.0, 136.1, 128.9, 128.8, 127.9, 127.0,
120.7, 116.5, 59.2, 53.19, 53.15, 39.4, 37.6, 23.4, 17.9, 13.3, 13.2. HRMS-FAB: m/z calcd for C22H26NO5 [M + H]+: 384.1811; found: 384.1783. CHIRALPAK AD, hexane-2-PrOH (90:10), 1 mL/min, t
R = 9.74 min (major isomer) and 14.1 min (minor isomer).
Compound (+)-3ae: mp 134.8-136.2 °C; [α]D
25 +9.34 (c 1.88, CHCl3, 58% ee). IR (neat): 2954, 1735, 1667, 1617, 1575, 1266 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.48-7.28 (m, 1 H), 7.16-6.91 (m, 3 H), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.76
(s, 3 H), 3.47 (s, 2 H), 3.40 (s, 2 H), 2.06 (s, 3 H), 1.82 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 171.7, 171.6, 163.5, 154.6, 150.1, 136.7, 129.9, 129.4, 128.0, 121.1, 120.3,
116.1, 112.0, 59.2, 55.7, 53.2, 53.1, 39.4, 37.6, 17.4, 13.2. CHIRALPAK AD-H, hexane-2-PrOH
(90:10), 1.0 mL/min, t
R = 15.3 min (major isomer) and 36.6 min (minor isomer).
Compound (+)-3af: colorless solid; mp 126.8-127.6 °C; [α]D
25 +29.6 (c 1.89, CHCl3, 56% ee). IR (neat): 2954, 2924, 1735, 1670, 1621, 1575, 1266 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.58-7.49 (m, 1 H), 7.43-7.33 (m, 2 H), 7.25-7.17 (m, 1 H), 3.79 (s, 3 H),
3.78 (s, 3 H), 3.49 (s, 2 H), 3.41 (s, 2 H), 2.07 (s, 3 H), 1.84 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 171.6, 171.4, 163.2, 150.6, 137.2, 135.7, 132.5, 130.4, 129.9, 128.0, 120.8,
116.6, 59.2, 53.20, 53.19, 39.4, 37.5, 17.4, 13.1. CHIRALPAK AD, hexane-2-PrOH (80:20),
1.0 mL/min, t
R = 6.48 min (major isomer) and 9.49 min (minor isomer).
Compound (+)-3ag: colorless solid; mp 159.8-161.1 °C; [α]D
25 +60.0 (c 1.29, CHCl3, 87% ee). IR (neat): 2954, 2924, 1735, 1669, 1620, 1574, 1263 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.72 (dd, J = 7.5, 1.2 Hz, 1 H), 7.45 (dt, J = 7.5, 1.2 Hz, 1 H), 7.30 (dt, J = 7.5, 1.5 Hz, 1 H), 7.23 (dd, J = 7.5, 1.5 Hz, 1 H), 3.80 (s, 3 H), 3.79 (s, 3 H), 3.50 (s, 2 H), 3.42 (s, 2 H),
2.08 (s, 3 H), 1.84 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 171.6, 171.4, 163.1, 150.6, 138.9, 135.6, 133.6, 130.0, 129.9, 128.7, 122.8,
120.9, 116.7, 59.2, 53.22, 53.19, 39.4, 37.5, 17.6, 13.1. CHIRALPAK AD, hexane-2-PrOH
(90:10), 1.0 mL/min, t
R = 13.9 min (major isomer) and 23.8 min (minor isomer).
Compound (+)-3be: colorless solid; mp 120.0-121.2 °C; [α]D
25 +14.7 (c 2.30, CHCl3, 68% ee). IR (neat): 2923, 1666, 1614, 1574, 1500, 1109 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.42-7.31 (m, 1 H), 7.14-6.95 (m, 3 H), 3.77 (s, 3 H), 3.39 (s, 5 H), 3.37
(s, 3 H), 3.34 (s, 2 H), 2.72 (s, 2 H), 2.64 (s, 2 H), 2.03 (s, 3 H), 1.78 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 163.6, 154.7, 152.9, 136.6, 129.7, 129.5, 128.3, 121.1, 120.4, 118.2, 111.9,
75.9, 75.7, 59.2, 55.7, 47.3, 37.7, 35.7, 30.3, 17.3, 13.1. CHIRALPAK AD, hexane-2-PrOH
(90:10), 1.0 mL/min, t
R = 7.71 min (major isomer) and 11.6 min (minor isomer).
Compound (+)-3ce: colorless solid; mp 143.0-143.3 °C; [α]D
25 +15.8 (c 1.34, CHCl3, 55% ee). IR (neat): 2930, 1644, 1581, 1528, 1500, 1277, 1246 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.44-7.31 (m, 1 H), 7.13-6.96 (m, 3 H), 3.77 (s, 3 H), 2.62 (s, 2 H), 2.50
(s, 2 H), 2.08 (s, 3 H), 1.84 (s, 3 H), 1.81-1.62 (m, 4 H). 13C NMR (75 MHz, CDCl3): δ = 162.2, 154.5, 147.3, 138.9, 129.7, 129.3, 128.7, 122.5, 121.1, 113.0, 111.9,
55.7, 28.2, 26.3, 22.9, 22.4, 16.2, 12.0. CHIRALPAK AD-H, hexane-2-PrOH (90:10), 1.0
mL/min, t
R = 7.19 min (major isomer) and 10.3 min (minor isomer).
Compound (+)-3de: pale yellow solid; mp 138.5-139.9 °C; [α]D
25 +18.9 (c 1.09, CHCl3, 40% ee). IR (neat): 2922, 2843, 1676, 1581, 1499 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.46-7.34 (m, 1 H), 7.15-6.95 (m, 3 H), 4.95 (m, 2 H), 4.92 (m, 2 H), 3.79
(s, 3 H), 2.03 (s, 3 H), 1.80 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 163.7, 154.5, 149.4, 134.8, 130.1, 129.4, 127.4, 121.2, 117.6, 115.8, 112.0,
72.1, 71.2, 55.7, 17.7, 13.2. CHIRALPAK AD-H, hexane-2-PrOH (90:10), 1.0 mL/min, t
R = 11.3 min (major isomer) and 16.2 min (minor isomer).
Compound (+)-3ee: colorless solid; mp 280 °C (dec.); [α]D
25 +12.2 (c 0.319, CHCl3, 34% ee). IR (neat): 2921, 2851, 1674, 1624, 1579, 1343 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.79 (d, J = 8.1 Hz, 2 H), 7.47-7.28 (m, 1 H), 7.37 (d, J = 8.1 Hz, 2 H), 7.11-6.94 (m, 3 H), 4.43 (s, 3 H), 4.40 (s, 3 H), 3.75 (s, 3 H),
2.45 (s, 3 H), 1.99 (s, 3 H), 1.77 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 163.2, 154.4, 146.0, 144.0, 136.8, 133.2, 130.2, 129.9, 129.2, 127.6, 127.1,
121.2, 120.0, 112.8, 112.1, 55.7, 52.2, 51.1, 21.5, 17.5, 13.1. CHIRALPAK IA, hexane-CH2Cl2 (50:50), 0.8 mL/min, t
R = 27.5 min (major isomer) and 34.0 min (minor isomer).
Compound (-)-5: pale yellow oil; [α]D 25-17.2 (c 0.330, CHCl3, 79% ee). IR (neat): 2925, 2853, 1669 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.47-7.35 (m, 1 H), 7.17-6.95 (m, 3 H), 6.33 (s, 1 H), 5.94 (d, J = 1.2 Hz, 1 H), 3.78 (s, 3 H), 2.43 (t, J = 7.5 Hz, 2 H), 2.33-1.99 (m, 2 H), 1.71-1.50 (m, 2 H), 1.45-0.99 (m, 30 H), 0.97-0.72
(m, 6 H). 13C NMR (75 MHz, CDCl3): δ = 163.9, 155.4, 154.8, 149.7, 130.1, 129.7, 127.0, 121.1, 115.8, 112.2, 106.6,
55.8, 35.5, 33.0, 31.90, 31.87, 29.61, 29.55, 29.49, 29.45, 29.4, 29.33, 29.29, 29.26,
29.1, 29.0, 27.8, 22.68, 22.66, 14.12, 14.10. CHIRALPAK AD, hexane-2-PrOH (95:5),
0.8 mL/min, t
R = 18.5 min (minor isomer) and 21.2 min (major isomer).
<A NAME="RU02508ST-18">18</A>
The high enantioselectivity observed in the reaction of 1a with 2a might be ascribed to a larger steric hindrance of 2a than those of 2b and 2c.
<A NAME="RU02508ST-19">19</A>
Kitagawa O.
Izawa H.
Sato K.
Dobashi A.
Taguchi T.
J. Org. Chem.
1998,
63:
2634